![]() |
市場調査レポート
商品コード
1417696
Gタンパク質共役受容体市場レポート:2030年までの動向、予測、競合分析G Protein Coupled Receptor Market Report: Trends, Forecast and Competitive Analysis to 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
Gタンパク質共役受容体市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
|
Gタンパク質共役受容体の動向と予測
世界のGタンパク質共役受容体市場は、2024年から2030年までのCAGRが6.7%で、2030年までに推定87億米ドルに達すると予想されています。この市場の主な促進要因は、心血管疾患の有病率の上昇、革新的な医薬品や治療法の創出を目指した研究開発に関連するコストの増大、ドラッグデリバリープロセスの採用拡大などです。世界のGタンパク質共役受容体市場の将来は、がん研究、中枢神経系研究、代謝研究、心血管研究、呼吸器研究、炎症研究の各市場における機会によって有望視されています。
Gタンパク質共役受容体市場の洞察
Lucintelは、細胞株は多様な検査に利用可能であり、GPCR標的を同定するための細胞インピーダンス実験では細胞株の使用が重要であるため、予測期間中も最大セグメントであり続けると予測しています。
北米は、がん研究への資金提供、GPCR標的薬の承認、研究開発と創薬イニシアチブの重点化により、予測期間中も最大地域であり続けると思われます。
Q1.市場規模は?
A1.世界のGタンパク質共役受容体市場は、2030年までに推定87億米ドルに達すると予想されています。
Q2.市場の成長予測は?
A2.世界のGタンパク質共役受容体市場は、2024年から2030年にかけてCAGR 6.7%で成長すると予想されています。
Q3.市場の成長に影響を与える主な促進要因は?
A3.この市場の主な促進要因は、心血管疾患の有病率の上昇、革新的な医薬品や治療法の創出を目指した研究開発に関連するコストの増大、ドラッグデリバリープロセスの採用拡大です。
Q4.市場の主要セグメントは?
A4.世界のGタンパク質共役受容体市場の将来は、がん研究、中枢神経系研究、代謝研究、心血管研究、呼吸器研究、炎症研究の各市場における機会によって有望視されています。
Q5.市場の主要企業は?
A5.Gタンパク質共役受容体の主要企業は以下の通りです。
Q6.今後、最大となる市場セグメントは?
A6.Lucintel社では、細胞株は検査に利用できる種類が豊富であること、GPCR標的を同定するための細胞インピーダンス実験では細胞株の使用が重要であることから、予測期間中も最大セグメントであり続けると予測しています。
Q7.市場において、今後5年間に最大になると予想される地域は?
A7.北米は、がん研究への資金提供、GPCR標的薬の承認、研究開発と創薬への取り組みがより重視されていることから、予測期間中も最大地域であり続けると思われます。
Q8.レポートのカスタマイズは可能?
A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。
G Protein Coupled Receptor Trends and Forecast
The future of the global G protein coupled receptor market looks promising with opportunities in the cancer research, CNS research, metabolic research, cardiovascular research, respiratory research, and inflammation research markets. The global G protein coupled receptor market is expected to reach an estimated $8.7 billion by 2030 with a CAGR of 6.7% from 2024 to 2030. The major drivers for this market are rising prevalence of cardiovascular diseases, growing costs associated with research and development efforts aimed at creating innovative pharmaceutical products and treatment, along with the increasing adoption of drug delivery processes.
A more than 150-page report is developed to help in your business decisions.
G Protein Coupled Receptor by Segment
The study includes a forecast for the global G protein coupled receptor by product, assay type, application, and region.
List of G Protein Coupled Receptor Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies G protein coupled receptor companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the G protein coupled receptor companies profiled in this report include-
G Protein Coupled Receptor Market Insights
Lucintel forecasts that cell lines will remain the largest segment over the forecast period because a wide variety of cell lines are available for the tests, and the use of cell lines is crucial in cellular impedance experiments used to identify GPCR targets.
North America will remain the largest region over the forecast period because of the funds for cancer research, the approving of GPCR-targeted medications, and a stronger emphasis on the region's drug development and discovery initiatives.
Features of the Global G Protein Coupled Receptor Market
Market Size Estimates: G protein coupled receptor market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: G protein coupled receptor market size by product, assay type, application, and region in terms of value ($B).
Regional Analysis: G protein coupled receptor market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product, assay type, application, and regions for the G protein coupled receptor market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the G protein coupled receptor market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the G protein coupled receptor market size?
Answer: The global G protein coupled receptor market is expected to reach an estimated $8.7 billion by 2030.
Q2. What is the growth forecast for G protein coupled receptor market?
Answer: The global G protein coupled receptor market is expected to grow with a CAGR of 6.7% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the G protein coupled receptor market?
Answer: The major drivers for this market are rising prevalence of cardiovascular diseases, growing costs associated with research and development efforts aimed at creating innovative pharmaceutical products and treatment, along with the increasing adoption of drug delivery processes.
Q4. What are the major segments for G protein coupled receptor market?
Answer: The future of the global G protein coupled receptor market looks promising with opportunities in the cancer research, CNS research, metabolic research, cardiovascular research, respiratory research, and inflammation research markets.
Q5. Who are the key G protein coupled receptor market companies?
Answer: Some of the key G protein coupled receptor companies are as follows.
Q6. Which G protein coupled receptor market segment will be the largest in future?
Answer: Lucintel forecasts that cell lines will remain the largest segment over the forecast period because a wide variety of cell lines are available for the tests, and the use of cell lines is crucial in cellular impedance experiments used to identify GPCR targets.
Q7. In G protein coupled receptor market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period because of the funds for cancer research, the approving of GPCR-targeted medications, and a stronger emphasis on the region's drug development and discovery initiatives.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.